Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Create Medic CoTSE:5187 +0.44%82 Debt-to-EBITDA is 0.35 as of Jun. 2026, which is 42% below its 10-year median of 0.60. GuruFocus rates TSE:5187 with a GF Score™ of 82/100 and a GF Value™ of 円1,089.85 (Fairly Valued). The stock has 4 warning signs investors should review. Among 471 Medical Devices & Instruments companies, Create Medic Co ranks better than 71.97% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Create Medic Co's Debt-to-EBITDA or its related term are showing as below:
TSE:5187'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.46 Med: 0.6 Max: 1.67
Current: 0.5
During the past 13 years, the highest Debt-to-EBITDA Ratio of Create Medic Co was 1.67. The lowest was 0.46. And the median was 0.60.
TSE:5187's Debt-to-EBITDA is ranked better than 71.97% of 471
companies
in the Medical Devices & Instruments industry
Industry Median: 1.63
vs TSE:5187: 0.50
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Create Medic Co Debt-to-EBITDA Related Terms
Create Medic Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Create Medic Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:5187 vs ABT, SYK, MDT: Debt-to-EBITDA Comparison
For the Medical Devices subindustry, Create Medic Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Create Medic Co Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Create Medic Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Create Medic Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Create Medic Co (TSE:5187) has a Debt-to-EBITDA of 0.35 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Create Medic Co. This is 42% below median its historical median of 0.60. Over the past decade, Create Medic Co's Debt-to-EBITDA has ranged from 0.46 to 1.67. According to the industry distribution chart, Create Medic Co ranks #132 out of 471 companies in the Medical Devices & Instruments industry, placing it in the top 28%.
Is Create Medic Co's Debt-to-EBITDA too high?
Create Medic Co's current Debt-to-EBITDA of 0.35 is 42% below median its 10-year median of 0.60. Over the past 10 years, this metric has ranged from a low of 0.46 to a high of 1.67. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.63. Create Medic Co's value of 0.35 is 78.5% below this industry median. Based on the distribution chart, Create Medic Co ranks #132 out of 471 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Create Medic Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Create Medic Co's Debt-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Create Medic Co ranks #132 out of 471 companies for Debt-to-EBITDA. This puts Create Medic Co in the upper half of its industry. The industry median Debt-to-EBITDA is 1.63. Create Medic Co's value of 0.35 is 78.5% below this benchmark. Historically, Create Medic Co's own Debt-to-EBITDA has ranged from 0.46 to 1.67 over the past decade. While the company's 10-year median is 0.60 vs. the industry median of 1.63, Create Medic Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.63, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Create Medic Co's current Debt-to-EBITDA of 0.35 is 78.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Create Medic Co. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Create Medic Co's current Debt-to-EBITDA is 0.35, which is 42% below median its own 10-year median of 0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Create Medic Co stock overvalued right now?
Based on GuruFocus' analysis, Create Medic Co (TSE:5187) is currently considered Fairly Valued. The stock's GF Value™ is 円1,089.85, compared to a current price of 円1,149.00 — trading 5.4% above its estimated fair value. The current Debt-to-EBITDA is 0.35, which is 42% below median its 10-year median of 0.60 and 78.5% below the Medical Devices & Instruments industry median of 1.63. Create Medic Co's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Create Medic Co (TSE:5187), the current Debt-to-EBITDA is 0.35 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Create Medic Co (TSE:5187) Overvalued in 2026?
Based on GuruFocus' analysis, Create Medic Co stock appears to be overvalued.
The current stock price of 円1,149.00 is trading 5.4% above its estimated GF Value™ of 円1,089.85.
GuruFocus considers Create Medic Co to be Fairly Valued.
Key valuation signals for TSE:5187:
Debt-to-EBITDA: 0.35 (42% below median its 10-year median of 0.60)
GF Value™: 円1,089.85 vs. price of 円1,149.00 (5.4% above fair value)
Industry Position: 78.5% below the Medical Devices & Instruments median (#132 of 471)
No single metric tells the full story. See the TSE:5187 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Create Medic Co Ltd is engaged in the research, manufacture and sale of medical appliances made of silicone rubber. It provides various urology, gastroenterology, percutaneous endoscopic gastrostomy, and surgery products.
82GF Score
Get the complete analysis for TSE:5187
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:5187 has been successfully added to your 
